<DOC>
	<DOCNO>NCT02204839</DOCNO>
	<brief_summary>The investigator hypothesise reduce basal insulin dose ( Glargine , Lantus , Sanofi-Aventis , Detemir , Levemir , Novo Nordisk ) , whilst employ current carbohydrate feed rapid-acting insulin dose recommendation protect patient type 1 diabetes early- late-onset hypoglycaemia follow evening time exercise .</brief_summary>
	<brief_title>Combined Basal-bolus Insulin Post-exercise Carbohydrate Feeding Strategy T1DM</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Aged 1850 year old ( male female ) . Free diabetes related complication ( apart mild background diabetic retinopathy ) . HbA1c &lt; 8.5 % . Not take prescribe medication insulin , treat stable insulin regimen compose combination slow/long act insulin ( glargine detemir ) fastacting insulin analogue ( lispro aspart ) , minimum 6 month start study . Demonstrate normal cardiac function response exercise . Aged young 18 , old 50 year . Suffering , diagnose diabetes related complication ( apart mild background diabetic retinopathy ) . HbA1c &gt; 8.5 % . Currently take prescribe medication , currently treat stable basal bolus regimen compose combination glargine determir , lispro aspart least 6 month start study . Failure demonstrate normal cardiopulmonary response exercise , medical condition could prevent completion exercise exacerbate .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>T1DM , Exercise , Hypoglycaemia</keyword>
</DOC>